Tesamorelin: The FDA-Approved Peptide That Goes After Deep Belly Fat
Most peptides you hear about online come with a lot of excitement and not much paperwork. Tesamorelin is the exception. It has an FDA approval, two large human trials behind it, and a very specific talent: shrinking the deep fat that sits around your organs.
So why isn't everyone talking about it? Because that approval covers one specific group of people. Here's the whole story, the promise first.
Evidence Grade: FDA-approved
(for one use: excess abdominal fat in adults with HIV-associated lipodystrophy). Other uses are still being studied.
What Is Tesamorelin?
Tesamorelin is a lab-made version of growth hormone-releasing hormone (GHRH), the signal your brain uses to tell your pituitary gland to release growth hormone. Instead of adding growth hormone from outside, it nudges your body to release more of its own. That raises a downstream hormone called IGF-1.
The FDA approved it as Egrifta on November 10, 2010, for adults with HIV whose medications caused fat to build up around the abdomen (NEJM Journal Watch). A newer formulation, Egrifta WR, was approved on March 25, 2025 (Theratechnologies).
One important detail: the label says it is not for weight loss. It's described as weight-neutral. It changes where fat sits, not necessarily what the scale says (FDA label).
Why Women Are Curious
There's fat you can pinch, and there's visceral fat: the deeper kind packed around your liver and other organs. That deeper kind is the one doctors care about most for metabolic health, and it's the kind that diet and exercise can be slow to budge. A peptide with human trial data on exactly that? Of course it's trending.
What the Human Research Shows
Belly fat. In the first big trial, published in the New England Journal of Medicine in 2007, 412 adults with HIV and abdominal fat gain were randomized to tesamorelin or placebo for 26 weeks. Visceral fat fell 15.2% on tesamorelin and rose 5.0% on placebo. Triglycerides dropped by 50 mg/dL, versus a 9 mg/dL rise on placebo. Fat under the skin didn't change, which is the point: it targets the deep stuff.
The FDA label pools two phase 3 trials of about 400 people each. At 26 weeks, visceral fat changed by −18% vs. +2% in one trial and −14% vs. −2% in the other (FDA label).
Liver fat. A 2019 randomized, double-blind trial in The Lancet HIV followed 61 people with HIV and fatty liver for 12 months. Tesamorelin cut liver fat by 37% relative to where people started. By the end, 35% of the tesamorelin group had liver fat back under the 5% threshold, compared with 4% on placebo. Blood sugar measures didn't differ between groups.
The brain (the most intriguing frontier). In a 2012 study in Archives of Neurology, 137 adults aged 55 to 87, some healthy and some with mild cognitive impairment, took tesamorelin or placebo for 20 weeks. Executive function, the mental juggling behind planning and multitasking, improved compared with placebo (Alzforum). The authors called the effects modest and asked for larger, longer trials. That's exactly the kind of signal worth following.
What About Women Specifically?
This is where the frontier opens up. Women made up roughly 14% to 16% of the people in the two approval trials (FDA label). Researchers are now looking beyond HIV: an NIH-funded, year-long, placebo-controlled trial at Massachusetts General Hospital was designed to test tesamorelin in 60 people with fatty liver disease who don't have HIV (GlobeNewswire). For a midlife woman without HIV, the data simply haven't caught up with the curiosity yet, which is what makes the next round of results worth watching.
What Happens When You Stop?
The effect needs ongoing treatment. In the trial extensions, people who switched from tesamorelin to placebo saw visceral fat climb back by 22% and 16% over the next six months, while those who stayed on it held steady (FDA label).
Side Effects: What to Know
From the 26-week trials on the FDA label (tesamorelin vs. placebo):
• Injection site reactions: 17% vs. 6% (redness, itching, pain)
• Joint pain: 13% vs. 11%
• Muscle pain: 6% vs. 2%
• Swelling in the legs or feet: 6% vs. 2%
• Blood sugar: 5% of people on tesamorelin reached an HbA1c of 6.5% or higher (the diabetes range), vs. 1% on placebo, so glucose is checked before and during treatment
• Fluid retention: can show up as swelling, joint aches or carpal tunnel symptoms
• Allergic reactions: reported in 4% of trial participants
• Higher IGF-1: monitored by doctors, since long-term effects of persistently high levels aren't known
The label says it should not be used during pregnancy, with an active cancer, or with certain pituitary conditions. Long-term cardiovascular safety has not been established.
When Should You Be Concerned?
Get emergency help for hives, swelling of the face or throat, or trouble breathing.
Call your clinician if you notice:
• Intense thirst, frequent urination or blurry vision (possible high blood sugar)
• Numbness or tingling in your hands
• New swelling in your ankles, feet or hands
• A rash or reaction at the injection site that spreads or won't fade
• You become pregnant or are trying to
• You have a history of cancer
One more thing: the research above was done on the FDA-approved product under medical supervision. Vials sold online as "research use only" are not that product, and their purity and contents are unknown.
What We Know and What's Next
We know: in large human trials, tesamorelin reduces deep belly fat and liver fat in adults with HIV, with a clear side effect profile and an FDA approval behind it.
The frontier: whether those results translate to women without HIV, to midlife body changes, and to brain health. Trials outside HIV are the next chapter.
The Bottom Line
Tesamorelin is one of the best-documented peptides out there, and it does one thing very well: it shrinks the deep fat that matters most for metabolic health. Right now that's proven in one population. For everyone else, it's a peptide to watch, and to talk through with a clinician rather than an influencer.
Your turn: If a peptide could change one thing about how your body stores fat, what would you want it to be?
This post is for educational purposes only and is not medical advice.
Sources
Comments